Skip to main content
Web Page

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival 10.1016/S1470-2045(09)70311-0 : The Lancet Oncology | ScienceDirec

N/ACitations
Citations of this article
2Readers
Mendeley users who have this article in their library.

Cite

CITATION STYLE

APA

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival 10.1016/S1470-2045(09)70311-0 : The Lancet Oncology | ScienceDirec. (n.d.). Retrieved from http://www.sciencedirect.com/science/article/pii/S1470204509703110

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free